Home Applications 211333 Application 211333
Type ANDA
Sponsor VISTAPHARM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FELBAMATE FELBAMATE SUSPENSION;ORAL 600MG/5ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211333-001 FELBAMATE FELBAMATE 600MG/5ML SUSPENSION / ORAL AB RS 2019-05-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A211333-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB RS 2019-05-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A211333-001 FELBAMATE 600MG/5ML SUSPENSION / ORAL AB 2019-05-31 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 66689-825 Felbamate Felbamate VistaPharm, Inc. ANDA Current 70954-051 Felbamate Felbamate Novitium Pharma LLC ANDA Current